[Form 4] MICROVISION, INC. Insider Trading Activity

Rhea-AI Filing Summary

MicroVision, Inc. reporting person Simon Biddiscombe, an Executive Vice Chair and Director, received a grant of 241,000 restricted stock units (RSUs) on 10/01/2025. The RSUs convert unit-for-share at vesting with no cash payment required, and are scheduled to vest in full on 10/01/2026 provided the reporting person continues service through that date. The Form 4 discloses the transaction date as 10/01/2025 and the filing was signed by an attorney-in-fact on 10/02/2025. The report records direct beneficial ownership of 0 common shares following the grant because the RSUs have not yet vested.

Insights

Corporate Governance Expert

Grant aligns executive compensation with shareholder outcomes through time‑based vesting.

The filing shows a time‑based equity award of 241,000 RSUs to Simon Biddiscombe with a single vest date of 10/01/2026, contingent on continued service. Time‑based vesting is a standard governance practice to retain senior management and align incentives with long‑term share performance.

The award converts to common shares at vesting without payment, which will create additional outstanding shares only if and when vesting occurs; the filing reports 0 vested shares today.

Compensation Analyst

This is a straightforward restricted stock unit grant with no exercise price and a one‑year vesting horizon.

The RSUs have an effective grant date of 10/01/2025, an exercise/convert price of $0.00, and are scheduled to vest on 10/01/2026 if service continues. That means the recipient will receive one share per unit at vesting without payment.

From a compensation perspective, the award is time‑based rather than performance‑based, so payout depends solely on continued service rather than meeting financial or market milestones.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BIDDISCOMBE SIMON

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice Chair

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00(1)	10/01/2025		M		241,000		10/01/2026(2)	10/01/2026(2)	Common stock	241,000	$0.00	0	D

Explanation of Responses:

1. At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.

2. RSUs granted 10/01/2025 are scheduled to vest in full on 10/01/2026, provided that the reporting person continues to provide services to the Company through the vest date.

	/s/ Drew G. Markham, attorney-in-fact for Simon Biddiscombe	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MicroVision insider Simon Biddiscombe receive on 10/01/2025 (MVIS)?

He was granted 241,000 restricted stock units (RSUs) on 10/01/2025.

When do the RSUs granted to Simon Biddiscombe vest (MVIS)?

The RSUs are scheduled to vest in full on 10/01/2026, subject to continued service through that date.

Will Simon Biddiscombe pay to receive shares at vesting (MVIS)?

No. The RSUs convert to common shares on a unit‑for‑share basis at vesting with a conversion price of $0.00.

How many common shares does Simon Biddiscombe beneficially own after the reported transaction (MVIS)?

The Form 4 reports 0 common shares beneficially owned following the grant because the RSUs have not vested.

When was the Form 4 for this transaction signed and filed (MVIS)?

The Form 4 shows the transaction date as 10/01/2025 and the signature by attorney‑in‑fact dated 10/02/2025.